Literature DB >> 18066556

Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease.

Miki Fujimura1, Tomohiro Kaneta, Teiji Tominaga.   

Abstract

OBJECT: Surgical revascularization for moyamoya disease prevents cerebral ischemic attacks by improving cerebral blood flow (CBF). It is undetermined, however, how rapid increase in CBF affects chronic ischemic brain during the acute stage in childhood moyamoya disease.
MATERIALS AND METHODS: The present study includes nine consecutive cases of patients with childhood moyamoya disease (2 to approximately 8 years old, 6.2 in average), who underwent superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis on 17 hemispheres. We prospectively performed single-photon emission computed tomography 1 and 7 days after 17 surgeries. The follow-up period ranged from 12 to 37 months (24.9 in average).
RESULTS: The outcome of 17 surgeries was excellent (disappearance of transient ischemic attack) in 14 hemispheres (82.4%) and good (reduction of transient ischemic attack) in three hemispheres (17.6%). No patient suffered peri-operative infarction, except for one (5.9%) manifesting as pseudolaminar necrosis in a part of the cerebral cortex supplied by STA-MCA bypass at the subacute stage, which did not affect his long-term neurological status. One patient (5.9%) presented with transient facial palsy due to hyperperfusion, which resolved within several days. No patient manifested permanent neurological deterioration during the follow-up period.
CONCLUSION: The STA-MCA anastomosis is a safe and effective treatment for childhood moyamoya disease. We recommend routine CBF measurement for avoiding surgical complications including both cerebral ischemia and hyperperfusion.

Entities:  

Mesh:

Year:  2007        PMID: 18066556     DOI: 10.1007/s00381-007-0551-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  19 in total

Review 1.  Cerebral hyperperfusion syndrome.

Authors:  Walther N K A van Mook; Roger J M W Rennenberg; Geert Willem Schurink; Robert Jan van Oostenbrugge; Werner H Mess; Paul A M Hofman; Peter W de Leeuw
Journal:  Lancet Neurol       Date:  2005-12       Impact factor: 44.182

2.  Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease.

Authors:  Seung-Ki Kim; Kyu-Chang Wang; In-One Kim; Dong Soo Lee; Byung-Kyu Cho
Journal:  Neurosurgery       Date:  2002-01       Impact factor: 4.654

3.  Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy.

Authors:  Kuniaki Ogasawara; Keiko Yamadate; Masakazu Kobayashi; Hidehiko Endo; Takeshi Fukuda; Kenji Yoshida; Kazunori Terasaki; Takashi Inoue; Akira Ogawa
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

Review 4.  Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis.

Authors:  Miki Fujimura; Teiji Tominaga; Pak H Chan
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism.

Authors:  R Shirane; Y Yoshida; T Takahashi; T Yoshimoto
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

6.  Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications.

Authors:  K Houkin; T Ishikawa; T Yoshimoto; H Abe
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

7.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Shunji Mugikura; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2007-03

8.  Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report.

Authors:  Kuniaki Ogasawara; Nobukazu Komoribayashi; Masakazu Kobayashi; Takeshi Fukuda; Takashi Inoue; Keiko Yamadate; Akira Ogawa
Journal:  Neurosurgery       Date:  2005-06       Impact factor: 4.654

9.  Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.

Authors:  Miki Fujimura; Hiroaki Shimizu; Shunji Mugikura; Teiji Tominaga
Journal:  Surg Neurol       Date:  2008-03-04

10.  Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Hiroaki Shimizu; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2007-05-08       Impact factor: 1.475

View more
  10 in total

1.  Moyamoya disease and arteriovenous fistula of the epiaortic vessels.

Authors:  K Savio; D Mittino; E Terazzi; I Divenuto; R Fossaceca; A Carriero; F Monaco
Journal:  Neurol Sci       Date:  2010-06-05       Impact factor: 3.307

2.  Regional cerebral perfusion and ischemic status after standard superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery in ischemic cerebrovascular disease.

Authors:  Jie Bai; Yuan-li Zhao; Rong Wang; Dong Zhang; Shuo Wang; Ji-zong Zhao; Jun Wu
Journal:  Childs Nerv Syst       Date:  2012-01-04       Impact factor: 1.475

3.  Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.

Authors:  Ramin A Morshed; Adib A Abla; Daniel Murph; Jasmin M Dao; Ethan A Winkler; Jan-Karl Burkhardt; Kathleen Colao; Steven W Hetts; Heather J Fullerton; Michael T Lawton; Nalin Gupta; Christine K Fox
Journal:  J Clin Neurosci       Date:  2020-08-19       Impact factor: 1.961

4.  Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Authors:  Sherif Rashad; Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

5.  Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Hiroaki Shimizu; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2009-01-22       Impact factor: 3.042

6.  Efficacy of superficial temporal artery-middle cerebral artery double anastomoses in a patient with rapidly progressive moyamoya disease: case report.

Authors:  Michiko Yokosawa; Toshiaki Hayashi; Reizo Shirane; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-02-28       Impact factor: 1.742

Review 7.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

Review 8.  Significance of Cerebral Blood Flow Analysis in the Acute Stage after Revascularization Surgery for Moyamoya Disease.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-15       Impact factor: 1.742

Review 9.  Progress on Complications of Direct Bypass for Moyamoya Disease.

Authors:  Jinlu Yu; Lei Shi; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

10.  Effect of Adventitial Dissection of Superficial Temporal Artery on the Outcome of Superficial Temporal Artery-Middle Cerebral Artery Bypass in Moyamoya Disease.

Authors:  Xin Li; Zheng Huang; Ming-Xing Wu; Dong Zhang
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.